Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.10.0.1
Commitments and Contingencies (Details) - Memorial Sloan Kettering Cancer Center [Member]
6 Months Ended
Jun. 30, 2018
USD ($)
New Drug Application [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 750,000
Receipt of regulatory approval from the U.S. FDA [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 1,750,000